IOVS The Oncologist
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kennedy, A.
Right arrow Articles by Mancini, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kennedy, A.
Right arrow Articles by Mancini, M. A.

Investigative Ophthalmology & Visual Science, Vol 27, 746-754, Copyright © 1986 by Association for Research in Vision and Ophthalmology


ARTICLES AND REPORTS

In vitro production of glycosaminoglycans by retinal microvessel cells and lens epithelium

A Kennedy, RN Frank and MA Mancini

Analysis of bovine lens capsules and retinal microvessel basement membranes by cellulose acetate electrophoresis, together with treatment by specific enzymes or by nitrous acid, reveals that heparan sulfate is the only demonstrable glycosaminoglycan (GAG), consistent with the observations of most other investigators on basement membrane preparations from several different tissues. When bovine retinal microvessel pericytes or endothelial cells or bovine lens epithelial cells are grown in culture in the presence of [35S]-sulfate or [3H]- glucosamine, however, both cellulose acetate electrophoresis and gel filtration chromatography reveal that the cultured pericytes synthesize primarily chondroitin sulfate, whereas the lens epithelial cells and microvascular endothelial cells produce a mixture of GAGs consisting of approximately 60% heparan sulfate and 40% chondroitin sulfate. The chondroitin sulfate chains have an Mr of 70,000, but the Mr of the heparan sulfate chains is 10,000, based on gel filtration chromatography on Sepharose CL-6B. Hence, cell culture conditions may produce phenotypic modulation of the biosynthetic capacities of these cells for GAGs. However, the difference between the in vitro and in vivo findings may in part be explained if many of the chondroitin sulfate GAGs synthesized in vitro are cell associated and are not incorporated into the basement membrane.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by the Association for Research in Vision and Ophthalmology